Lai C H Eric, Lau W Y
Department of Surgery, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
Surgeon. 2008 Feb;6(1):45-8. doi: 10.1016/s1479-666x(08)80094-7.
Endoscopic retrograde cholangiopancreatography (ERCP)-related perforation occurs in 0.1-1.8% of patients after therapeutic ERCP. It is a serious complication with a high mortality. However, little evidence exists in the medical literature and the optimal management remains unclear. This review aims to critically evaluate the optimal management of therapeutic ERCP-related perforation.
内镜逆行胰胆管造影术（ERCP）相关穿孔发生在接受治疗性ERCP的患者中的比例为0.1%-1.8%。这是一种严重并发症，死亡率很高。然而，医学文献中的证据很少，最佳治疗方案仍不明确。本综述旨在严格评估治疗性ERCP相关穿孔的最佳治疗方案。
